NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.71% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.64% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 5.86% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.54% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.05% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.00% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 3.47% |
DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.45% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.82% |
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.73% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.66% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.38% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.30% |
SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 2.24% |
VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.12% |
LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.09% |
ARGX | Argen-X | Healthcare | Biotechnology | 2.07% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.02% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 1.99% |